Patent · US Active

Methods and compositions for treating distress dysfunction and enhancing safety and efficacy of specific medications

US8617577B2 · kind B2 · utility

7Cited by
11References
6Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 11, 2013
Grant dateDec 31, 2013
Priority date
Expiry dateFeb 11, 2033

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P37/08
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates to methods and compositions for reducing distress dysfunction, including emotional and physical distress. The invention entails co-administration of at least one Receptor Switcher and at least one Endorphin Enhancer. Additionally, at least one Synergistic Enhance and/or at least one Exogenous Opioid are also administered to enhance or prolong the therapeutic effects.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.